Hims & Hers Health (HIMS) Long-Term Debt Repayments (2020)
Hims & Hers Health's (HIMS) quarterly Long-Term Debt Repayments came in at $357000.0 in Q2 2020, down 69.17% quarter-over-quarter from $1.2 million in Q1 2020.
Hims & Hers Health (HIMS) Long-Term Debt Repayments (2020) Analysis & Trends
Hims & Hers Health has disclosed Long-Term Debt Repayments across 1 years of filings, most recently posting $357000.0 for Q2 2020.
- Long-Term Debt Repayments for Q2 2020 came in at $357000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2021 was $357000.0 (changed N/A YoY), and the FY2020 annual result was $1.5 million, down 83.26% from the prior year.
- Long-Term Debt Repayments came in at $357000.0 for Q2 2020 at Hims & Hers Health, down from $1.2 million in the prior quarter.
- In the past five years, Long-Term Debt Repayments ranged from a high of $1.2 million in Q1 2020 to a low of $357000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 23.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 216,000.00 |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | 19.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 357,000.00 |
| Jun 30, 2020 | 357,000.00 |
| Mar 31, 2020 | 1.16 Mn |
| Mar 31, 2020 | 1.16 Mn |